SEC Form 4 · accession 0001008161-15-000006
AIM ImmunoTech Inc. · AIM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William A Carter
Officer — CEO · Director · 10% Owner
Period of report
Aug 18, 2015
Accepted (ET)
Aug 19, 2015 · 9:27 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000946644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 18, 2015 | P | 25,000 | $0.182 | A | 1,200,585 | D |
Table II — derivative securities
No Table II lines on this filing.